| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |